-
Anal Cancer - Pipeline Review, H2 2019 Published: November, 2019 - Pages: 475 - US$ 2,000.00 More info
-
Rectal Cancer - Pipeline Review, H2 2019 Published: November, 2019 - Pages: 186 - US$ 2,000.00 More info
-
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2019 Published: November, 2019 - Pages: 109 - US$ 2,000.00 More info
-
Thyroid Cancer - Pipeline Review, H2 2019 Published: November, 2019 - Pages: 825 - US$ 2,000.00 More info
-
Esophageal Cancer - Pipeline Review, H2 2019 Published: November, 2019 - Pages: 1233 - US$ 2,000.00 More info
-
Hypopharyngeal Cancer - Pipeline Review, H2 2019 Published: November, 2019 - Pages: 311 - US$ 2,000.00 More info
-
Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 Published: November, 2019 - Pages: 113 - US$ 1,875.00 Year-End Deals More info
-
Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 Published: November, 2019 - Pages: 132 - US$ 3,000.00 Year-End Deals More info
-
Breast Cancer Diagnostic and Drug Technologies: Global Markets Published: November, 2019 - Pages: 150 - US$ 5,500.00 More info
-
Global Cancer Vaccine Partnering 2014-2019: Deal trends, players and financials Published: November, 2019 - Pages: 120 - US$ 2,545.75 Year-End Deals More info
-
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 Published: July, 2018 - Pages: 152 - US$ 3,746.25 Year-End Deals More info
-
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 Published: May, 2018 - Pages: 215 - US$ 3,746.25 Year-End Deals More info
-
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Pre... Published: December, 2017 - Pages: 155 - US$ 3,746.25 Year-End Deals More info
-
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 Published: April, 2017 - Pages: 176 - US$ 3,746.25 Year-End Deals More info
-
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Incre... Published: March, 2017 - Pages: 161 - US$ 3,746.25 Year-End Deals More info
-
Non-Small Cell Lung Cancer (NSCLC) - China Drug Forecast and Market Analysis to 2025 Published: November, 2016 - Pages: 478 - US$ 3,746.25 Year-End Deals More info
-
Non-Small Cell Lung Cancer (NSCLC) - Japan Drug Forecast and Market Analysis to 2025 Published: November, 2016 - Pages: 478 - US$ 3,746.25 Year-End Deals More info
-
Non-Small Cell Lung Cancer (NSCLC) - US Drug Forecast and Market Analysis to 2025 Published: November, 2016 - Pages: 479 - US$ 3,746.25 Year-End Deals More info
-
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biolog... Published: February, 2016 - Pages: 171 - US$ 3,746.25 Year-End Deals More info
-
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New ... Published: January, 2015 - Pages: 126 - US$ 3,746.25 Year-End Deals More info